• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[哥伦比亚布卡拉曼加有永久居留意愿的移民中SARS-CoV-2血清流行率及相关因素。哥伦比亚布卡拉曼加有永久居留意愿的移民中SARS-CoV-2的血清流行率及相关因素。]

[SARS-CoV-2 seroprevalence and associated factors among migrants with a vocation for permanence, Bucaramanga, ColombiaSoroprevalencia de SARS-CoV-2 e fatores associados em migrantes com vocaao de permanencia, Bucaramanga, Colombia.].

作者信息

Martínez-Vega Ruth Aralí, Bolívar-Grimaldos Alix, Rincón-Orozco Bladimiro

机构信息

. Universidad de Santander, Escuela de Medicina, Bucaramanga, Colombia. Email:

. Laboratorios Bolívar, Bucaramanga, Colombia. Email:

出版信息

Rev Cuid. 2023 Mar 29;13(3):e2657. doi: 10.15649/cuidarte.2657. eCollection 2022 Sep-Dec.

DOI:10.15649/cuidarte.2657
PMID:40115359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11559309/
Abstract

INTRODUCTION

There are few reports assessing anti-SARS-CoV-2 seroprevalence in the migrant population in the world. These studies help to understand the exposure of populations to the virus to take actions to reduce the impact of SARS-CoV-2 infection.

OBJECTIVE

To determine the anti-SARS-CoV-2 seroprevalence in migrants with a vocation for permanence in Bucaramanga and to identify factors associated with previous SARS-CoV-2 infection.

METHODS

Analytical cross-sectional study using consecutive sampling, which included adult migrants in Bucaramanga in February 2021. Surveys were conducted, and chemiluminescent immunoassays were performed to detect IgM and IgG antibodies to SARS-CoV-2 in serum samples. Prevalence ratios (PR) were estimated using a log-binomial regression model.

RESULTS

The study enrolled 462 participants. IgM seroprevalence was 11.7% (95% CI 9.1-14.9), IgG seroprevalence was 32.9% (95% CI 28.8-37.3), and IgM or IgG seroprevalence was 36.1% (95% CI 31.9-40.6). Contact with a confirmed case of COVID-19 (PR:1.54; 95% CI 1.04-2.29) or suspected case (PR:1.56; 95% CI 1.13-2.16); living with six or more people (PR: 1.52; 95% CI 1.05-2.20); stay in Colombia > 2 years (PR:1.43; 95% CI 1.11-1.92), and presence of symptoms (PR:1.62; 95%CI 1.26-2.10) were some factors associated with higher IgG seroprevalence.

DISCUSSION

In Bucaramanga, SARS-CoV-2 seroprevalence among migrants was similar to the seroprevalences of migrants in Kuwait but lower than migrants in Paris and Singapore.

CONCLUSIONS

The anti-SARS-CoV-2 seroprevalence among migrants with a vocation for permanence was similar to that reported among residents of Bucaramanga. Contact with suspected or confirmed COVID-19 cases and crowded conditions were some of the factors associated with seroprevalence.

摘要

引言

世界上评估移民人群中抗SARS-CoV-2血清流行率的报告较少。这些研究有助于了解人群对该病毒的暴露情况,以便采取行动减少SARS-CoV-2感染的影响。

目的

确定打算永久居住在布卡拉曼加的移民中抗SARS-CoV-2血清流行率,并确定与既往SARS-CoV-2感染相关的因素。

方法

采用连续抽样的分析性横断面研究,纳入了2021年2月在布卡拉曼加的成年移民。进行了调查,并对血清样本进行化学发光免疫分析以检测抗SARS-CoV-2的IgM和IgG抗体。使用对数二项回归模型估计患病率比(PR)。

结果

该研究纳入了462名参与者。IgM血清流行率为11.7%(95%CI 9.1-14.9),IgG血清流行率为32.9%(95%CI 28.8-37.3),IgM或IgG血清流行率为36.1%(95%CI 31.9-40.6)。与确诊的COVID-19病例(PR:1.54;95%CI 1.04-2.29)或疑似病例(PR:1.56;95%CI 1.13-2.16)接触;与六人或更多人一起生活(PR:1.52;95%CI 1.05-2.20);在哥伦比亚停留超过2年(PR:1.43;95%CI 1.11-1.92),以及出现症状(PR:1.62;95%CI 1.26-2.10)是与较高IgG血清流行率相关的一些因素。

讨论

在布卡拉曼加,移民中的SARS-CoV-2血清流行率与科威特移民的血清流行率相似,但低于巴黎和新加坡的移民。

结论

打算永久居住的移民中抗SARS-CoV-2血清流行率与布卡拉曼加居民中报告的情况相似。与疑似或确诊的COVID-19病例接触以及拥挤的居住条件是与血清流行率相关的一些因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/11559309/f215e2f4aba5/2346-3414-cuid-13-03-e2657-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/11559309/edab4eb31ad3/2346-3414-cuid-13-03-e2657-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/11559309/f215e2f4aba5/2346-3414-cuid-13-03-e2657-gf2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/11559309/edab4eb31ad3/2346-3414-cuid-13-03-e2657-gf1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8e3b/11559309/f215e2f4aba5/2346-3414-cuid-13-03-e2657-gf2.jpg

相似文献

1
[SARS-CoV-2 seroprevalence and associated factors among migrants with a vocation for permanence, Bucaramanga, ColombiaSoroprevalencia de SARS-CoV-2 e fatores associados em migrantes com vocaao de permanencia, Bucaramanga, Colombia.].[哥伦比亚布卡拉曼加有永久居留意愿的移民中SARS-CoV-2血清流行率及相关因素。哥伦比亚布卡拉曼加有永久居留意愿的移民中SARS-CoV-2的血清流行率及相关因素。]
Rev Cuid. 2023 Mar 29;13(3):e2657. doi: 10.15649/cuidarte.2657. eCollection 2022 Sep-Dec.
2
Seroprevalence of SARS-CoV-2 Infection among Occupational Groups from the Bucaramanga Metropolitan Area, Colombia.哥伦比亚布卡拉曼加大都市区职业人群中 SARS-CoV-2 感染的血清流行率。
Int J Environ Res Public Health. 2021 Apr 15;18(8):4172. doi: 10.3390/ijerph18084172.
3
Post-migration infection with SARS-CoV-2 in Venezuelan migrants: A laboratory-based epidemiological observational study.委内瑞拉移民中 SARS-CoV-2 的迁移后感染:一项基于实验室的流行病学观察性研究。
Travel Med Infect Dis. 2024 Nov-Dec;62:102772. doi: 10.1016/j.tmaid.2024.102772. Epub 2024 Oct 17.
4
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
5
Antibody tests for identification of current and past infection with SARS-CoV-2.用于识别当前和既往感染新型冠状病毒2的抗体检测。
Cochrane Database Syst Rev. 2020 Jun 25;6(6):CD013652. doi: 10.1002/14651858.CD013652.
6
Assessment of the COVID-19 pandemic progression in Ecuador through seroprevalence analysis of anti-SARS-CoV-2 IgG/IgM antibodies in blood donors.通过对献血者血液中抗 SARS-CoV-2 IgG/IgM 抗体的血清阳性率分析来评估厄瓜多尔的 COVID-19 疫情进展。
Front Cell Infect Microbiol. 2024 Jun 21;14:1373450. doi: 10.3389/fcimb.2024.1373450. eCollection 2024.
7
[Seroprevalence of anti-SARS-CoV-2 IgG/IgM antibodies in Borgosesia (Piedmont Region, Northern Italy) population: a surveillance strategy in post-lockdown period?].[意大利北部皮埃蒙特大区博尔戈塞西亚人群中抗SARS-CoV-2 IgG/IgM抗体的血清流行率:封锁后时期的监测策略?]
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):200-206. doi: 10.19191/EP20.5-6.S2.119.
8
Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis.欧洲、美国和东亚医护人员在接种疫苗前SARS-CoV-2 IgG抗体的血清流行率:一项系统评价和荟萃分析。
EClinicalMedicine. 2021 Mar;33:100770. doi: 10.1016/j.eclinm.2021.100770. Epub 2021 Mar 8.
9
Seroprevalence of SARS-CoV-2-specific anti-spike IgM, IgG, and anti-nucleocapsid IgG antibodies during the second wave of the pandemic: A population-based cross-sectional survey across Kashmir, India.在印度克什米尔第二次大流行期间,SARS-CoV-2 特异性抗刺突 IgM、IgG 和抗核衣壳 IgG 抗体的血清阳性率:一项全人群横断面调查。
Front Public Health. 2022 Oct 6;10:967447. doi: 10.3389/fpubh.2022.967447. eCollection 2022.
10
Seroprevalence of anti-SARS-CoV-2 antibodies in Iquitos, Peru in July and August, 2020: a population-based study.2020年7月和8月秘鲁伊基托斯抗新冠病毒抗体的血清流行率:一项基于人群的研究。
Lancet Glob Health. 2021 Jul;9(7):e925-e931. doi: 10.1016/S2214-109X(21)00173-X. Epub 2021 May 19.

本文引用的文献

1
The prevalence of SARS-CoV-2 antibodies in quarantine workers and high-risk communities in Vietnam.越南检疫工作人员和高危社区中新型冠状病毒抗体的流行情况。
IJID Reg. 2022 Mar;2:137-140. doi: 10.1016/j.ijregi.2021.12.001. Epub 2021 Dec 11.
2
Trends in social exposure to SARS-Cov-2 in France. Evidence from the national socio-epidemiological cohort-EPICOV.法国人群中 SARS-CoV-2 社会暴露趋势。来自全国社会流行病学队列-EPICOV 的证据。
PLoS One. 2022 May 25;17(5):e0267725. doi: 10.1371/journal.pone.0267725. eCollection 2022.
3
Contrasting SARS-CoV-2 epidemics in Singapore: cohort studies in migrant workers and the general population.
新加坡的 SARS-CoV-2 疫情对比:移民工人和一般人群的队列研究。
Int J Infect Dis. 2022 Feb;115:72-78. doi: 10.1016/j.ijid.2021.11.043. Epub 2021 Dec 2.
4
Seroprevalence of SARS-CoV-2 antibodies in the general population of Oman: results from four successive nationwide sero-epidemiological surveys.阿曼普通人群中 SARS-CoV-2 抗体的血清流行率:四项连续全国血清流行病学调查的结果。
Int J Infect Dis. 2021 Nov;112:269-277. doi: 10.1016/j.ijid.2021.09.062. Epub 2021 Sep 30.
5
A systematic and meta-analysis review on the diagnostic accuracy of antibodies in the serological diagnosis of COVID-19.一项关于新冠病毒病血清学诊断中抗体诊断准确性的系统评价与荟萃分析
Syst Rev. 2021 May 26;10(1):155. doi: 10.1186/s13643-021-01689-3.
6
Seroprevalence of SARS-CoV-2 Infection among Occupational Groups from the Bucaramanga Metropolitan Area, Colombia.哥伦比亚布卡拉曼加大都市区职业人群中 SARS-CoV-2 感染的血清流行率。
Int J Environ Res Public Health. 2021 Apr 15;18(8):4172. doi: 10.3390/ijerph18084172.
7
Prevalence and Outcomes of SARS-CoV-2 Infection Among Migrant Workers in Singapore.新加坡农民工中 SARS-CoV-2 感染的流行率和结局。
JAMA. 2021 Feb 9;325(6):584-585. doi: 10.1001/jama.2020.24071.
8
Seroprevalence and risk factors of exposure to COVID-19 in homeless people in Paris, France: a cross-sectional study.法国巴黎无家可归者中 COVID-19 的血清流行率和暴露风险因素:一项横断面研究。
Lancet Public Health. 2021 Apr;6(4):e202-e209. doi: 10.1016/S2468-2667(21)00001-3. Epub 2021 Feb 6.
9
Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays.使用商业酶联免疫吸附试验和化学发光免疫分析方法推断住院 COVID-19 患者血清中 SARS-CoV-2 刺突结合中和抗体效价。
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):485-494. doi: 10.1007/s10096-020-04128-8. Epub 2021 Jan 6.
10
Seroprevalence of SARS-CoV-2 in migrant workers in Kuwait.科威特外来务工人员中新冠病毒的血清流行率。
J Travel Med. 2021 Feb 23;28(2). doi: 10.1093/jtm/taaa223.